Note this is a video recording of an online meeting conducted using the Zoom.us platform. Inevitably such recordings suffer a little in terms of their production values because of the internet connectivity and quality of webcams. Despite that, they allow us to provide additional valuable insights in to the MedComms business and we can involve a wider range of speakers who can participate from the comfort of their own desks, wherever in the world they are.

In this webinar, we will be discussing AI as it relates to the medical writing sphere, from ChatGPT through to the current tools on the market. We will be cracking out our crystal balls and thinking about where this brave new world of automation can lead medical writers – both on the regulatory side and on the medcomms side, and ultimately we will be asking if using AI is an opportunity or a threat for medical writers. Our panellists today are Lisa Chamberlain James (Senior Partner), Barry Drees (Senior Partner) and Jamie Norman (Chief Product Officer), all from Trilogy Writing & Consulting. And we answer questions from the audience.

It should be of interest to anyone who is working in and around MedComms, or who is wanting to join the business.

Recorded 05 April as a MedComms Networking webinar. Produced by NetworkPharma.tv

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

Lisa’s LinkedIn page is at https://www.linkedin.com/in/lisa-chamberlain-james-1ab3287/

Jamie’s LinkedIn page is at https://www.linkedin.com/in/jamienorman/

Find out more about Trilogy Writing & Consulting at https://trilogywriting.com/
Find out more about TriloDocs at https://trilogywriting.com/trilodocs/

Further reading:

The article referred to by Jamie is as follows…

GPTs are GPTs: An Early Look at the Labor Market Impact Potential of Large Language Models
See https://arxiv.org/pdf/2303.10130.pdf

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =  = = = = = = = = = = = = =

We are building a library of free webcasts and other video content for the global MedComms Community and others at networkpharma.tv and we’d welcome your suggestions for new content.

[For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like. Cheers Peter Llewellyn, Director NetworkPharma Ltd and Founder of the MedComms Networking Community activity at medcommsnetworking.com]